Top

Published in:

01-12-2017 | Case report

Bee venom allergy immunotherapy

Mild systemic reaction characterised by skin and subcutaneous tissues disorder: case report

Published in: Reactions Weekly | Issue 1/2017

Excerpt

In a retrospective study, a 4-year-old child [sex not stated] was described who developed mild systemic reaction characterised by skin and subcutaneous tissues disorder characterised following therapy with bee venom allergy immunotherapy [bee venom; route not stated]. The child was placed in conventional venom allergy immunotherapy [CVIT] group. The child received bee venom allergy immunotherapy 50µg injection and developed mild systemic reaction characterised by skin and subcutaneous tissues disorder [duration of treatment to reaction onset and outcome not stated]. …

Rosman Y, et al. Venom Immunotherapy in High-Risk Patients: The Advantage of the Rush Build-Up Protocol. International Archives of Allergy and Immunology 174: 45-51, No. 1, Oct 2017. Available from: URL: http://doi.org/10.1159/000479692 - IsraelCrossRefPubMed

Title: Bee venom allergy immunotherapy
Mild systemic reaction characterised by skin and subcutaneous tissues disorder: case report
Publication date: 01-12-2017
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2017
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-017-39351-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Bee venom allergy immunotherapy

Mild systemic reaction characterised by skin and subcutaneous tissues disorder: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2017

Bupivacaine/fentanyl

Gefitinib/osimertinib

Unithiol

Calcitonin

CNTO-2476

Levamisole abuse